Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion sustained-release versus escitalopram for major depressive disorder
CTR20131491Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion, escitalopram in major depressive disorder (MDD), sponsored by GSK. Started Apr 2015; status: completed.
02
Drugs
bupropionescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20131491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131491.